1. Revelle M (1995) Progress in blood supply safety. FDA Cons 29:21–24
2. Chamberland ME (2001) Emerging infectious disease issues in blood safety. Emerg Infect Dis 7:552–553
3. Hayden RT (2004) (2004). In vitro nucleic acid amplification techniques. In: Persing DH, Tenover FC, Versalovic J, Tang YW, Unger ER, Relman DA, White TJ (eds) Molecular microbiology: diagnostic principles and practice. ASM, Washington, DC, pp 43–69
4. Guichon A, Chiparelli H, Martinez A, Rodriguez C, Trento A, Russi JC, Carballal G (2004) Evaluation of a new NASBA assay for the qualitative detection of hepatitis C virus based on the NucliSens Basic Kit reagents. J Clin Virol 29:84–91
5. Starkey WG, Millar RM, Jenkins ME, Ireland JH, Muir KF, Richards RH (2004) Detection of piscine nodaviruses by real-time nucleic acid sequence based amplification (NASBA). Dis Aquat Organ 5:93–100